Despite advances in the understanding of head and neck squamous cell carcinomas (HNSCC) progression, the five-year survival rate remains low due to local recurrence and distant metastasis. One hypothesis to explain this recurrence is the presence of cancer stem-like cells (CSCs) that present inherent chemo-and radio-resistance. In order to develop new therapeutic strategies, it is necessary to have experimental models that validate the effectiveness of targeted treatments and therefore to have reliable methods for the identification and isolation of CSCs. To this end, we present a protocol for the isolation of CSCs from human HNSCC cell lines that relies on the combination of two successive cell sortings performed by fluorescence activated cell sorting (FACS). The first one is based on the property of CSCs to overexpress ATP-Binding Cassette (ABC) transporter proteins and thus exclude, among others, vital DNA dyes such as Hoechst 33342. The cells sorted with this method are identified as a "side population" (SP). As the SP cells represent a low percentage (<5%) of parental cells, a growing phase is necessary in order to increase their number before the second cell sorting. The next step allows for the selection of cells that possess two other HNSCC stem cell characteristics i.e. high expression level of the cell surface marker CD44 (CD44 high ) and the over-expression of aldehyde dehydrogenase (ALDH high ). Since the use of a single marker has numerous limitations and pitfalls for the isolation of CSCs, the combination of SP, CD44 and ALDH markers will provide a useful tool to isolate CSCs for further analytical and functional assays requiring viable cells. The stem-like characteristics of CSCs was finally validated in vitro by the formation of tumorispheres and the expression of β-catenin.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy worldwide and despite progress in current treatments, patients with advanced disease have a poor prognosis. The overall 5 year survival rate of the patient is around 30% despite the combination of therapeutic approaches including surgery, chemo-radiotherapy and targeted-therapies. Recent studies attribute local recurrence and distant metastasis to the survival of cancer stem-like cells (CSCs) following anticancer therapies 1 . There is accumulating evidence supporting the existence of cells presenting stem cells properties (undifferentiated status, self-renewal and differentiation capacities, and telomerase activity) in various solid tumors including breast, brain, prostate, lung, colon, pancreas, liver and skin [2] [3] [4] [5] [6] [7] [8] [9] [10] . However, the origin of CSCs remains unclear 11, 12 . They may result from the malignant transformation of normal stem cells 3, 13 or dedifferentiation of tumor cells that acquire CSCs-like features 14, 15 . Therefore, understanding distinctive pathways relating to CSCs will provide insight into early diagnosis and treatment of resistant HNSCC.
It has been proposed that CSCs also possess resistant phenotypes that evade standard chemotherapy and radiotherapy, resulting in tumor relapse compared to the bulk of tumor cells [16] [17] [18] [19] and are localized into hypoxic niches 20 . Numerous factors have been proposed to explain these resistances of CSCs, such as propensity to quiescence, enhanced DNA repair, up-regulated cell cycle control mechanisms, and free-radical scavenging 21 . Moreover, several oncogenic molecular pathways may be specifically activated in CSCs 17 . In order to improve knowledge of CSCs for further targeted-therapies, we need reliable methods for the identification and isolation of CSCs, owing to the heterogeneity of stem cellrelated markers in various types of cancers 22 .
In HNSCC, stem-like tumor-initiating cells have been isolated from primary patient tumors by sorting cells expressing different CSC biomarkers (such as drug efflux transporters expression 23 , CD44 high , CD24 low CD133 high , c-Met + phenotype 10, 24, 25 , or ALDH high activity 26 ) or cultivating primary patient tumor to form squamospheres that have CSC properties. Nevertheless, the number of squamospheres decreases dramatically after two passages, thus giving a small sample size for further characterization studies , including in head and neck cancer models [29] [30] [31] .
Moreover, CD44
high cells can generate in vivo a heterogeneous tumor whereas CD44 low cells cannot 10 . The SP assay is based on the differential potential of cells to efflux the Hoechst dye 22 via the ATP-binding cassette (ABC) family of transporter proteins overexpressed within the CSC membrane. This assay includes the use of ABC transporter inhibitors such as verapamil in control samples. Aldehyde dehydrogenase (ALDH) is an intracellular enzyme that is involved in converting retinol to retinoic acid during early stem cell differentiation 25, 26 . Cells that exhibit high ALDH activity show stem-like cell behavior in HNSCC 26 and a very few number of ALDH high cells are able to generate tumors in vivo 26, 32 .
The combination of these markers and properties was successfully used by Bertrand et al. to study the resistance in vitro and in vivo of these CSCs to photon and carbon ion radiation 19 . Their results clearly showed that the combination of various cell markers and properties are more selective for useful studies on HNSCC CSCs populations than single-marker approaches.
Protocol
All animal procedures were performed according to local guidelines on animal care. All the details of this study were approved by the CECCAPP, a French ethics committee. 2. Using the cytometer software, on the "Global Worksheet" window, click on "Dot Plot" (fifth top right picture) and create a chart on the global worksheet. On ordinate, with a right click, select FSC-A (forward scatter) and on abscissa, SSC-A (side scatter) ( Figure 1A) . In the same way, create a SSC-W versus SCC-H dot plot. On this second dot plot, to create a P1 region, click "Polygon gate" (fourteenth top right picture) ( Figure 1B ) 33 . Note: The P1 region will encompass single cells and discriminate doublets. 3. Optional: Exclude PI positive cells by creating a FSC-A versus PI gated on P1. On this dot plot, select the PI negative population (P2) to exclude PI positive dead cells. 4. Using the cytometer software, on the "Global Worksheet" window, click on "Dot Plot" and create a chart on the global worksheet.
On ordinate, with a right click, select blue Hoechst-A and on abscissa, red Hoechst-A. With a right click on the population, select "Show population" and P1. On this dot plot, create a region (P2) to select the negative Hoechst dye side population (SP) cells that appears as a side arm on the left of the main population of cells ( Figure 1C ).
2. Analyze the sample "Hoechst" and collect 10,000 events. To ensure that the gate P2, which represents the SP population, is well positioned, analyze the sample "Hoechst and Verapamil" (10,000 events) to observe the disappearance of SP population (Figure 1D ). 3. Collect the SP Hoechst dye negative cells in a 15 ml tube containing 1 ml of CM-CSC prepared in 1.1.1.1. 4. At the end of the cell sorting, centrifuge the cell suspension at 250 x g for 5 min, remove the supernatant and resuspend the pellet with 1 ml of CM-CSC. Count the number of sorted cells using a cell counter and transfer appropriate number of cells to a culture flask (see Table 1 ). Add CM-CSC and incubate at 37 °C and 5% CO 2 atmosphere. "Cell culture method"). Using the cytometer software, on the "Global Worksheet" window, click on "Dot Plot" and create a chart on the global worksheet. On ordinate, with a right click, select APC-A and on abscissa, FITC-A in order to select the double stained population. Create a gate using tubes d and e to select ALDH high cells (Figure 2A) . Note: Positive cells disappear in tube e treated with DEAB ( Figure 2B ).
Selection of the CD44
1. On the same chart, create a second gate using tubes b and c in order to select CD44 high cells (Figure 2C and 2D) . Positive cells disappear in the tube containing IgG1-APC. Analyze tubes f and g and create a third gate that includes CD44 high /ALDH high cells (Figure 2E and 2F) . Note: If positive cells are present in the tube containing IgG1-APC (Figure 2D) , the interaction between cells and the APCstained antibody is not specific.
Collect CD44
high /ALDH high cells into a 15 ml tube containing 1 ml of CM-CSC. Collect also CD44 low /ALDH low into a 15 ml tube containing 1 ml of CM 19 . Note: Prepare CM-CSC as described in step 1.1.1.1. 5. Centrifuge the cell suspension at 250 x g for 5 min, remove the supernatant and resuspend the pellet with 1 ml of CM-CSC. Count the number of sorted cells.
Cell Culture Method
1. After the double-sorting of the cells as described above, plate the sorted cells into an appropriate culture flask ( 
Confirmation of Tumor Potential and CSC Characteristics
1. Tumor Sphere Formation to Confirm the tumor Potential of the CD44 high /ALDH high Cells.
1. Trypsinize cells as described in 3.2. Add 1 x 10 6 cells to a 15 ml tube and centrifuge at 250 x g for 5 min. Remove the supernatant and re-suspend the pellet in a DMEM:F12 (3:1) medium FCS free, 20 ng/ml of rhEGF, 4 mg/L of heparin and 1x B27. Incubate cells in a 6 well low anchorage plates culture flask at 37 °C and 5% CO 2 .
Note: Use DMEM:F12 (3:1) medium containing 5% of FCS, 20 ng/ml of rhEGF, 4 mg/L of heparin and 1x B27 if cell do not grow without FCS. 2. Observe the tumor sphere formation with an optical microscope from 4 to 10 days after seeding (Figure 3A) .
Note: Tumor sphere diameter should be more than 35 µm. CD44 high /ALDH high cells will show a faster and more enhanced tumor sphere formation in terms of number and size compared to CD44 low /ALDH low .
Evaluation of In Vivo Tumorigenicity After Subcutaneous Injection of CD44
high /ALDH high Cells in NOD-SCID Mice.
1. After sorting, re-suspend cells in PBS at three different concentrations (10 4 cells/ml, 10 5 cells/ml, and 10 6 cells/ml). Inject subcutaneously 100 µl of 10 4 cells/ml (10 3 cells) in the right flank region of 6 mice. Do the same for 10 5 cells/ml (10 4 cells), and 10 6 cells/ml (10 5 cells).
Note: Lower dilution than 10 3 cells can be tested.
2. Inject the same concentration of CD44 low /ALDH low cells in the left flank region. Monitor injected mice for up to 10 weeks to see tumor progression 19 .
Representative Results
The isolation of CSCs from HNSCC cell lines required two successive sorting because of the very low percentage of CSCs in the parental cell line. The first sorting was based on the ability of CSCs to exclude the Hoechst dye due to drug efflux transporters. This resulted in acquisition of 1-5% of the total cell population sorted (Figure 1) . During the Hoechst dye negative cell sorting, check the size and granulation of sorted cells by looking at the FSC-A versus SSC-A dot plot (Figure 1A) . Then, discriminate doublets and cells fragments by using the SSC-W versus SSC-H dot plot and selecting the population P1 (Figure 1B) . On this P1 population, create a Hoechst Red-A versus Hoechst Blue-A dot plot. With the tube labeled "Hoechst", the SP appears as a side arm on the left from the main cells population (Figure 1C) . This population must disappear when they are treated with Verapamil (Figure 1D) , an inhibitor of ABC transporters. The PI staining allows the exclusion of PI-positive dead cells because this population is under-scale on the Hoechst Red-A scale (Figure 1C and 1D , blue ellipses).
The second cell sorting was based on the high expression of the CD44 receptor and high ALDH enzyme activity which allowed the acquisition of 0.5-2% from the SP cells previously sorted (Figure 2) . Before the sorting, various controls were used. The first ones are the "ALDH" and the "ALDH + DEAB" tubes needed in order to place the first gate on FITC high cells (Figures 2A and 2B) : ALDH high cells were gated on the FITC-A versus APC-A dot plot using the "ALDH" tube (Figure 2A) . The good position of the gate was checked using the "ALDH + DEAB" tube: as DEAB inhibits ALDH, positive cells must disappear from the gate (Figure 2B) . If they don't, change the reaction conditions (by increasing the amount of DEAB for example). The second control is the "CD44-APC" and the "IgG1-APC" tubes which allowed to position the second gate on APC high cells (Figures 2C and 2D) using the cells stained with the CD44-APC antibody (Figure 2C) . This population must disappear with the control tube which contained IgG1-APC cells (Figure 2D) . If it does not, the bond with the antibody is not specific and BSA 0.5% should be added into buffer 1 from the ALDH detection kit during the antibody reaction. Finally, the third control concerns the "ALDH and CD44-APC" tube and "ALDH, DEAB and CD44-APC" tubes (Figures 2E, 2F, 2G and 2H) . The double staining ALDH/CD44 tube is used to position the last gate on the double positive cells (Figure 2E ) and the same tube treated with DEAB is a control to verify that ALDH high cells disappear (Figure 2F) .
This protocol is used to sort CSCs from the SQ20B and the FaDu cell lines. When the sorting is done for the first time on a new cell line, in order to ensure that sorted cells have stem-like cells properties, it is necessary to confirm their tumor potential. One of the stem-like cell property is its ability to form tumorspheres in vitro in a FSC free medium. Under this condition, only cancer stem-like cells can survive and proliferate ( Figure  3A) . Moreover, qPCR experiments show a high expression of β-catenin (marker of stem-like characteristic) in CD44 high /ALDH high cells ( Figure   3B ), as well as Bmi-1 and Notch 19 . Finally, CD44 high /ALDH high cells are also able to form tumors when injected in low quantities as compared with CD44 low /ALDH low cells 19 . >1,000,000 1 T75 culture flask 2 10 Table 1 : Culture flask type to use according to the number of cells sorted. Details of the culture flask size for approximate number of cells sorted are given. The volume of trypsin and volume of medium required for the culture flask type are also provided.
Discussion
This protocol describes a reliable method for the successful isolation of CSCs from a specific cell line that is applicable to other HNSCC cell lines. Isolated head and neck CSCs are then suitable for further molecular characterization in vitro and functional validation by transplantation in immunodeficient mice 19 . However, some modifications can be tested depending on the side population or the CD44 high /ALDH high percentages present in the parental cell line. For example, if the percentage of cells in the side population is too low in a particular cell line, the CD44 high /
